Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine-Reference-Cited by-同舟云学术

Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine

Published:2012-11-20 Issue:6 Volume:54 Page:1268-1278
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wolska Anna,Cebula-Obrzut Barbara,Smolewski Piotr,Robak Tadeusz

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.741233

Reference42 articles.

1. Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and Alloantigens

2. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation

3. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells

4. Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells

5. Sensitization of IL-2 Signaling through TLR-7 Enhances B Lymphoma Cell Immunogenicity

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL;Leukemia Research;2024-08

2. NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy;Frontiers in Immunology;2024-06-11

3. The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies;Vaccines;2023-01-28

4. Unexpected CD5+ B Cell Lymphocytosis during SARS-CoV-2 Infection: Relevance for the Pathophysiology of Chronic Lymphocytic Leukemia;Journal of Clinical Medicine;2023-01-28

5. New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia;Expert Opinion on Drug Discovery;2017-08-04